Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Saline Breast Implant Makers Must Submit PMAs By Nov. 17, FDA Says

This article was originally published in The Gray Sheet

Executive Summary

Manufacturers of saline breast implants have until Nov. 17 to file either a premarket approval application, product development protocol or an investigational device exemption for their products or remove them from commercial distribution, FDA says in an Aug. 19 final rule.
Advertisement

Related Content

FDA, Congress Examine Saline Implant Data; Silicone PMA Expected In 2002
FDA, Congress Examine Saline Implant Data; Silicone PMA Expected In 2002
Panel Urges McGhan To Recharacterize "Inflated" Complication Rates
PIP Saline Implant Deemed "Not Approvable" Due To Paucity Of Data
PIP Saline Implant Deemed "Not Approvable" Due To Paucity Of Data
Panel Urges McGhan To Recharacterize "Inflated" Complication Rates
NovaMed Predicts Two Breast Implant Releases, Profitability By Year-End
NovaMed Predicts Two Breast Implant Releases, Profitability By Year-End
Saline Breast Implant Rule Comment Period Should Be Reopened - Law Firm
Advertisement
UsernamePublicRestriction

Register

MT012209

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel